Refine by
Horse Articles & Analysis: Older
22 news found
(OTCQX: IMPL) ("Impel" or "the Company"), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering from diseases with high unmet medical needs, today announced that it is pursuing a sale of the Company and has entered into an agreement with JN BIDCO LLC to serve as the "stalking horse" bidder to acquire the Company and ...
Featured Products Lectins X23-02-ZQ300 Agaricus bisporus lectin (ABL), Mushroom, Alexa Fluor 488 conjugate X23-02-ZQ301 Agaricus bisporus lectin (ABL), Mushroom, Alexa Fluor 594 conjugate Lectin Kits X23-02-ZQ734 Magnetic bead conjugated Concanavalin A (Con A) kit X23-02-ZQ735 Fucose-specific magnetic bead conjugated multi-lectin kit Lectin Antibodies X23-02-ZQ779 Rabbit ...
The Muscular Dystrophy Association is pleased to announce the award of an MDA Venture Philanthropy (MVP) grant totaling $233,200 to Scottsdale, Ariz.-based Iron Horse Diagnostics to support development of a prognostic test for ALS (amyotrophic lateral sclerosis). ...
BynVector
” Blue remarked that his company has gained significant acclaim and momentum due to its initial invention of the InSet technology, a stabilization glenoid system that addresses the “rocking horse effect” in shoulder implant recipients. The rocking horse effect occurs when the humerus both rotates and translates on the scapula as it articulates. ...
From offering “only” cell line development in our “working horse” Hansenula polymorpha, we nowadays offer the whole development chain for production processes for microbially expressed recombinant proteins. ...
We are glad to announce that scientists from our biotechnology company BlueSky Immunotherapies GmbH (Ltd.) have achieved great success in completely and permanently eliminating equine sarcoids and bovine papillomavirus that causes this aggressive form of skin cancer that horses often suffer from. By using its proprietary delNS technology, BlueSky Immunotherapies has created a ...
Ready for a New Game While chasing the ball during a polo game, the mallets up in the air, the horses doing their best, the players do not imagine how and what contributes to the stunning shape of the grass, of the surrounding bushes, of the gardens. ...
” Nebion’s biomedical data covers nine species—human, mouse, rat, and smaller species that include rhesus monkey, nematode, fruit fly, pig, and horse—supported by 63 platforms, including both bulk tissue and single-cell platforms. ...
ByImmunai
Epica International, the leader in advanced ultra-high-resolution mobile medical imaging and robotic applications for human health, animal health and industrial enterprises, announces new corporate headquarters and operations in Spartanburg County, S.C. What: Epica International, with offices in San Clemente, California and manufacturing and R&D facilities in Florence and Pisa, Italy ...
SPARTANBURG, SC – MAY 13, 2021 – Epica International, the leader in advanced ultra-high-resolution mobile medical imaging and robotic applications for human health, animal health and industrial enterprises, announces new corporate headquarters and operations in Spartanburg County, S.C. WHAT: Epica International, with offices in San Clemente, California and manufacturing and R&D ...
The ImmunoCAP Specific IgE Pet Allergen Components were also recently cleared by the FDA and can help improve the diagnosis of dog, cat and horse allergies. ImmunoCAP Specific IgE blood tests, which are available in most major U.S. laboratories, can be ordered for patients of any age regardless of skin condition, current medication, disease activity or pregnancy status. ...
“ A new boost for a tried and tested technology Fab’entech has expertise in the immunisation of horses using antigens of interest to produce polyclonal antibodies. These are then purified and subjected to enzymatic digestion to produce fragments of antibodies, known as F(ab’)2. ...
Schaumburg, III., April 11,2016 - Central Life Sciences, whose founders invented insect growth regulator (IGR) technology more than 35 years ago, today announced the launch of w^^w.mosquito-awareness.com. a site created to raise visibility of the potentially deadly diseases mosquitoes can spread, and educate visitors about preventing exposure and transmission. As part of an overall public ...
BioLargo, Inc. (OTCQB: BLGO) subsidiary Clyra Medical Technologies, Inc. has successfully concluded a financing from Sanatio Capital LLC for $750,000 in equity and a forward commitment to provide a $5,000,000 operating line of credit, to support the FDA approval and commercial launch of Clyra's advanced wound care products. Clyra Medical Technologies holds the exclusive license to commercialize ...
BioLargo, Inc. (OTCQB: BLGO) will present at the Rodman & Renshaw 16th Annual Global Investment Conference on Tuesday, September 9th at the New York Palace Hotel. Dennis Calvert, BioLargo's president, is scheduled to present at 2:55 p.m. ET. A webcast of the live presentation will be available at www.BioLargo.com where it will be retained for 90 days. A copy of the slides management will be ...
BioLargo, Inc.'s president and CEO Dennis Calvert was recently interviewed by SNN Live at two investor conferences. Mr. Calvert introduces BioLargo and discusses the company's progress in commercializing its advanced iodine platform technology. Video of both interviews can be accessed by clicking on the following links. Marcum's 3rd Annual MicroCap Conference in New York City on May 29th. ...
Opens recurring sales channels for health care related products - Establishes working capital line of credit to support sales efforts - BioLargo, Inc. (OTCQB: BLGO) announced its subsidiary Odor-No-More, Inc. was assigned National Stock Numbers (NSNs) for multiple products by the Defense Logistics Information Service (DLIS), allowing the U.S. military, and federal and civil agencies, to ...
Its Odor-No-More® product was awarded two Editor's Choice Awards, including a "Product of the Year" award, by the Horse Journal, a top industry publication, as well as a Best New Product SuperZoo Award, and are sold by BioLargo's wholly owned subsidiary, Odor-No-More, Inc. ...
The products were made by the same Florida pharmacy, Franck’s Compounding Lab, that produced the supplements responsible for killing 21 elite polo horses in 2009. All patients with the infections had undergone either eye surgeries or injections. ...
“Our trials so far have shown that the vaccine prevents the infection of horses with Hendra virus,” Dr Middleton said. Stopping the disease in horses could also help protect people from the disease. “A horse vaccine is crucial to breaking the cycle of Hendra virus transmission from flying foxes to horses and ...
